Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.35% |
| 2 | Healthcare | 2.86% |
| 3 | Financials | 2.56% |
| 4 | Consumer Discretionary | 2.22% |
| 5 | Industrials | 2.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
NOV
NOV
$7.09B
| $5.96M | ﹤0.01% |
285,200
+91,200
| +47% | +$1.91M |
|
|
CUK
3502
DELISTED
Carnival PLC
CUK
| $5.95M | ﹤0.01% |
827,617
-643,960
| -44% | -$4.96M |
|
3503
Recursion Pharmaceuticals
RXRX
$1.69B
| $5.95M | ﹤0.01% |
771,150
+269,280
| +54% | +$2.64M |
|
3504
PUT
TC Energy
TRP
$66.6B
| $5.94M | ﹤0.01% |
149,100
+103,100
| +224% | +$4.47M |
|
3505
Fulcrum Therapeutics
FULC
$288M
| $5.94M | ﹤0.01% |
816,244
+174,112
| +27% | +$1.14M |
|
3506
AdaptHealth
AHCO
$806M
| $5.93M | ﹤0.01% |
308,529
-101,789
| -25% | -$2.15M |
|
|
MRTX
3507
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.93M | ﹤0.01% |
130,800
+52,100
| +66% | +$3.37M |
|
3508
CALL
United Parks & Resorts
PRKS
$2.09B
| $5.91M | ﹤0.01% |
110,500
-28,800
| -21% | -$1.54M |
|
|
ICPT
3509
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.9M | ﹤0.01% |
477,129
+114,068
| +31% | +$1.62M |
|
3510
CALL
Lantheus
LNTH
$6.6B
| $5.9M | ﹤0.01% |
115,800
-123,200
| -52% | -$7.6M |
|
3511
HNI Corp
HNI
$3.53B
| $5.9M | ﹤0.01% |
207,556
+18,907
| +10% | +$538K |
|
3512
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.37B
| $5.9M | ﹤0.01% |
124,457
+76,470
| +159% | +$3.61M |
|
3513
CALL
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $5.9M | ﹤0.01% |
140,500
+61,000
| +77% | +$2.47M |
|
3514
NCR Voyix
VYX
$1.15B
| $5.9M | ﹤0.01% |
410,486
-980,787
| -70% | -$13M |
|
3515
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$435M
| $5.89M | ﹤0.01% |
295,998
+141,599
| +92% | +$2.51M |
|
3516
PUT
DTE Energy
DTE
$29.1B
| $5.89M | ﹤0.01% |
50,100
-61,000
| -55% | -$6.92M |
|
|
RETA
3517
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.88M | ﹤0.01% |
154,900
+29,900
| +24% | +$1.03M |
|
3518
CALL
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.6B
| $5.88M | ﹤0.01% |
151,300
-27,000
| -15% | -$1.03M |
|
3519
PUT
Cracker Barrel
CBRL
$1.3B
| $5.88M | ﹤0.01% |
62,100
-65,100
| -51% | -$6.78M |
|
3520
CALL
Cirrus Logic
CRUS
$6.23B
| $5.88M | ﹤0.01% |
78,900
-171,200
| -68% | -$12.3M |
|
3521
PUT
Principal Financial Group
PFG
$24.7B
| $5.87M | ﹤0.01% |
70,000
+47,200
| +207% | +$4.05M |
|
3522
Kadant
KAI
$3.95B
| $5.87M | ﹤0.01% |
33,032
+16,461
| +99% | +$2.93M |
|
3523
CALL
PVH
PVH
$3.99B
| $5.86M | ﹤0.01% |
83,000
-66,500
| -44% | -$3.96M |
|
3524
CALL
MasTec
MTZ
$20.8B
| $5.86M | ﹤0.01% |
68,648
+18,848
| +38% | +$1.55M |
|
3525
CALL
Axalta
AXTA
$8.03B
| $5.85M | ﹤0.01% |
229,500
-79,400
| -26% | -$1.96M |
|
Similar funds
Citadel Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Citadel Advisors held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in Denbury Inc. worth $107M.
- Citadel Advisors's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Citadel Advisors added most to Tesla in Q4 2022, an estimated $913M increase.
- Citadel Advisors's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Citadel Advisors fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Citadel Advisors's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Citadel Advisors opened 3,614 new positions and closed 1,312 in Q4 2022.
- Citadel Advisors's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.